Marketing go-ahead for clot-breaking brush
This article was originally published in Clinica
Executive Summary
The FDA has approved Micro Therapeutics' clot-breaking Cragg Thrombolytic Brush for use in the treatment of haemodialysis grafts. The brush is already marketed in Europe and Australia.